|
|
| Volume 18 • Issue 1 |
January 10, 2018 |
 |
|
|
 |
| |
 |
|
|
EDARBI AND EDARBYCLOR – NOTICE TO PHARMACISTS
Please update the Edarbi and Edarbyclor UPC codes if you haven’t ordered the
products in the last 12 months.
Read more
|
|
 |
| |
 |
|
|
WANT TO LEARN MORE ABOUT COLD-FX® AND THE CLINICALS BEHIND IT?
Click here to register to watch our online video: http://cold-fx.ca/healthcare-professionals/.
Registration required to access healthcare professional resources.
|
|
|
|
|
|
| |
 |
|
|
PREVENTION AND TREATMENT OF IRON DEFICIENCY
Read more
|
|
 |
| |
 |
|
|
BY AGE 40, ABOUT 50% OF THE POPULATION WILL HAVE OR HAVE HAD
A MENTAL ILLNESS
Read more
|
|
|
BULLETINS |
| |
| • |
Canadian Pharmacists are on the front line of the opioid crisis, and are uniquely able to provide patients and their families with support and counselling. The Canadian Pharmacists Association has created a number of resources including instructions on administering Naloxone nasal spray and Naloxone injection.
|
| • |
While pharmacists don’t currently dispense medical cannabis, pharmacists are the “go to” source for information regarding all types of medications. The Canadian Pharmacists Association has produced this Medical Cannabis Q&A to help answer patients' commonly asked questions about medical cannabis.
|
|
|
|
|
|
